Search for: "Eli Lilly "
Results 1081 - 1100
of 2,131
Sort by Relevance
|
Sort by Date
17 Jan 2012, 6:56 am
This translates into $20 billion in annual profits for pharmaceutical giants like Eli Lilly, Pfizer and Forest Pharmaceutical. [read post]
17 Jan 2012, 6:56 am
This translates into $20 billion in annual profits for pharmaceutical giants like Eli Lilly, Pfizer and Forest Pharmaceutical. [read post]
16 Jan 2012, 7:03 am
Cymbalta is manufactured by Eli Lilly and Co. [read post]
13 Jan 2012, 3:02 am
” The “anti-psychotics include AstraZeneca Plc (AZN)’s Seroquel and Eli Lilly & Co. [read post]
11 Jan 2012, 9:44 pm
In 1998 Takeda entered into a marketing partnership with Eli Lilly and Co. to push Actos in the United States and obtain FDA approval. [read post]
11 Jan 2012, 2:02 pm
Eli Lilly & Co., 119 F.3d 1559, 1566 (Fed. [read post]
10 Jan 2012, 11:58 pm
Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. [read post]
10 Jan 2012, 2:18 pm
While many in the State Senate support the bill, there are many small and large businesses such as Eli Lilly and Co. and Cummins, Inc. that do not support the bill. [read post]
5 Jan 2012, 5:28 pm
Gemzar previously yielded $750 million in annual revenues for Eli Lilly. [read post]
5 Jan 2012, 3:10 pm
Takeda and Eli Lilly & Company jointly promoted Actos in the United States since its launch in 1999; however as of 2006, Takeda solely assumed all marketing and sales responsibilities for Actos. [read post]
4 Jan 2012, 9:20 am
Takeda and Eli Lilly & Company jointly promoted Actos in the United States since its launch in 1999; however as of 2006, Takeda solely assumed all marketing and sales responsibilities for Actos. [read post]
3 Jan 2012, 5:38 pm
MDL Consolidation to eliminate duplicative discovery, prevent inconsistent pretrial rulings, and conserve the resources of the parties, their counsel and the judiciary Actos (pioglitazone) was marketed by Takeda Pharmaceuticals America Inc. and Eli Lilly and Co. in 1999 for the treatment of Type II diabetes. [read post]
29 Dec 2011, 9:00 pm
Armitage of Eli Lilly and Company, and Janet Gongola, Patent Reform Coordinator at the USPTO, helped in breaking down the AIA for the masses. 2) A New Doctrine of Equivalents? [read post]
29 Dec 2011, 9:00 pm
Armitage of Eli Lilly and Company, and Janet Gongola, Patent Reform Coordinator at the USPTO, helped in breaking down the AIA for the masses. 2) A New Doctrine of Equivalents? [read post]
29 Dec 2011, 6:50 am
Eli Lilly & Co., No. 1:07–cv–1133–SEB–TAB, 2008 WL 5384340, at *2 (S.D.Ind. [read post]
19 Dec 2011, 6:30 pm
—San Antonio 1997, orig. proceeding); see also Eli Lilly and Co. v. [read post]
18 Dec 2011, 7:37 pm
This includes an agreement by Otsuka Pharmaceutical to pay over $4 million in fines to resolve allegations of off-label marketing (drug approved to treat adult schizophrenia and bi-polar disorder, marketed for geriatric patients suffering from dementia-related psychosis), an agreement by Cephalon to pay $425 million for off-label drug marketing (narcotic drug approved for ppioid-tolerant cancer patients, marketed for migraines, sickle-cell pain crises, injuries, and other uses), a $1.415 billion… [read post]
15 Dec 2011, 2:10 am
But Eli Lilly simultaneously pursued parallel proceedings in the UK, seeking revocation of the patent on the basis that the assertions as to the effects and functions of Neutrokine-a were speculative, and merely presented the reader of the patent with a research project to go and try out. [read post]
12 Dec 2011, 9:17 am
By Eric Goldman Earlier this month, I attended an event at University of Colorado Boulder called “The Economics of Privacy,” sponsored by the Silicon Flatirons center. [read post]
8 Dec 2011, 9:32 am
Actos has been marketed in the U.S. by Eli Lilly & Company of Indianapolis. [read post]
